Home » Topics » BioWorld

BioWorld
RSS

LEUKINE NUDGES IMMUNEX INTO BLACK

July 26, 1991

RECORD SECOND-QUARTER REVENUES FOR GENZYME

July 25, 1991

THREE COMPANIES COMPLETE OFFERINGS

July 25, 1991

AMGEN SPLITS STOCK 3 FOR 1

July 25, 1991

APPLIED BIO TO ACQUIRE PHARMACO

July 25, 1991

PTO DECLARES ANTISENSING PATENT CONFLICT

July 25, 1991

CENTOCOR'S SEPSIS STUDY COMES UNDER FIRE

July 25, 1991

SYNERGEN REACQUIRES TROFAK RIGHTS

July 24, 1991

NEWS BRIEFS

July 24, 1991

ENZYTECH TO DEVELOP MAb DELIVERY FOR CENTOCOR

July 24, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...